ATC code N
ATC code N is a section of the Anatomical Therapeutic Chemical Classification System (ATC), which is used for the classification of drugs and other medical substances. This system is controlled by the World Health Organization (WHO) and is used internationally to facilitate the organization of medicines based on their therapeutic use and chemical characteristics.
Overview[edit]
ATC code N encompasses drugs that act on the nervous system, one of the major systems in the human body responsible for regulating bodily functions and responding to external stimuli. This category is divided into several subgroups based on the type of action the drugs have or the conditions they are used to treat.
Subgroups[edit]
The ATC code N includes the following subgroups:
- N01 - Anesthetics
- N02 - Analgesics
- N03 - Antiepileptics
- N04 - Anti-Parkinson drugs
- N05 - Psycholeptics
- N06 - Psychoanaleptics
- N07 - Other nervous system drugs
Each subgroup is further divided into more specific classes, focusing on particular types of drugs or treatments. For example, N02 includes opioids and non-opioid analgesics, and N05 includes antipsychotics and anxiolytics.
Usage[edit]
The ATC classification system, including ATC code N, is used by healthcare providers, researchers, and policymakers to streamline processes such as drug prescription, research, and regulatory review. It helps in organizing drug data, making it easier to access and analyze information regarding drug usage and its implications.
Importance[edit]
The classification of drugs into a systematic framework like the ATC system aids in ensuring safety, efficacy, and consistency in the use of medicines globally. It also supports the management of drug information in databases and contributes to international health statistics and reports.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian